[1] 李继恩,王旭东,姜在鹏,等.替吉奥口服联合三维适形放疗治疗三阴性乳腺癌效果观察[J].山东医药,2016,56(18):45-47. [2] Shimizuguchi T, Nihei K, Okano T, et al. A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer[J]. International Journal of Clinical Oncology, 2017, 22(2):373-379. [3] 任春旺,邓大平.全数字化钼靶X射线对乳腺癌的诊断价值[J].中国辐射卫生,2015,24(2):180-182. [4] 刘铁斌,宁智超,田平艳.腺癌保乳术后调强放疗与三维适形放疗的疗效比较[J].癌症进展,2017,15(3):321-324. [5] Kosztyla R, Pierce G, Ploquin N, et al. Poster-21:Verification of monitor unit calculations for breast field-in-field three-dimensional conformal radiotherapy plans[J]. Medical Physics, 2016, 43(8):4940-4941. [6] 吴剑,钟日奎,刘卓星.乳腺癌术后调强放射治疗的研究[J].临床和实验医学杂志,2016,15(13):1302-1306. [7] 刘广琥,余浩,汤洁.乳腺钼靶数字摄影技术在乳腺占位性病变中的应用价值[J].中国辐射卫生,2016,25(5):627-629. [8] 童琴,伍海彪,陈政颂,等.乳腺癌改良根治术后3种放疗技术的剂量学研究[J].实用医学杂志,2015,31(18):3016-3018. [9] Kumabe A, Fukuhara N, Utsunomiya T, et al. Three-dimensional conformal arc radiotherapy using a C-arm linear accelerator with a computed tomography on-rail system for prostate cancer:clinical outcomes[J]. Radiation Oncology, 2015,10:208. [10] 苏建淳,胡学锋,卢秋霞,等.左侧乳腺癌保乳术后调强放疗与常规放疗靶区内剂量均匀性心肺照射剂量和体积的差异分析[J].山西医药杂志,2017,46(14):1714-1716. [11] 马长春,李东升,伍方财,等.临床肿瘤靶区位移对左侧乳腺癌改良根治术后调强适形放疗的剂量学影响[J].实用医学杂志,2015,31(11):1801-1803. [12] Onimaru R, Hida K, Takeda N, et al. Palliative radiotherapy for thoracic spine metastases:Dosimetric advantage of three-dimensional conformal plans[J]. Oncology Letters, 2015, 10(1):497-501. [13] 刘凌湘,张超,邹国荣.乳腺癌改良根治术后逆向与混合调强放疗剂量学比较[J].中国医学物理学杂志,2015,32(5):742-746. [14] 周亭芳,邱波,付挺,等.乳腺癌改良根治术后调强放疗致放射性肺损伤的剂量学研究[J].广东医学,2015,36(22):3488-3490. [15] 王春宇, 王铁君, 毛铁铸,等. 角度变化对乳腺癌术后电子线放疗剂量分布影响研究[J]. 中国辐射卫生, 2016, 25(1):11-14.
